Flucytosine
- Generic Name
- Flucytosine
- Brand Names
- Ancobon
- Drug Type
- Small Molecule
- Chemical Formula
- C4H4FN3O
- CAS Number
- 2022-85-7
- Unique Ingredient Identifier
- D83282DT06
Overview
A fluorinated cytosine analog that is used as an antifungal agent.
Background
A fluorinated cytosine analog that is used as an antifungal agent.
Indication
For the treatment (in combination with amphotericin B) of serious infections caused by susceptible strains of Candida (septicemia, endocarditis and urinary system infections) and/or Cryptococcus (meningitis and pulmonary infections).
Associated Conditions
- Candidiasis
- Candidiasis, Systemic
- Cryptococcal infections
- Fungal Infections
- Fungal endocarditis
- Meningitis, Fungal
- Septicemia
- Urinary tract infection fungal
- Disseminated Cryptococcosis
Clinical Trials
FDA Approved Products
Flucytosine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/05/05
NDC:63629-2147
Flucytosine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/05/05
NDC:63629-9157
Flucytosine
Manufacturer:Sigmapharm Laboratories, LLC
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/01/10
NDC:42794-010
FLUCYTOSINE
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/03/02
NDC:59651-331
Flucytosine
Manufacturer:Novel Laboratories, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2022/05/06
NDC:40032-770
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath